Kuldeep Dhama, Firzan Nainu, Andri Frediansyah, Mohd. Iqbal Yatoo et al.
Newly emerging variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are continuously posing high global public health concerns and panic resulting in waves of coronavirus disease 2019 (COVID-19) pandemic. Depending on the extent of genomic variations, mutations and adaptation, fe...
Ali A. Rabaan, Shamsah H. Al-Ahmed, Javed Muhammad, Amjad Khan et al.
Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is a severe pandemic of the current century. The vicious tentacles of the disease have been disseminated worldwide with unknown complications and repercussions. Advanced COVID-19 syndrome is ...
L. J. Muhammad, Md. Milon Islam, Sani Sharif Usman, Safial Islam Ayon
Novel coronavirus (COVID-19 or 2019-nCoV) pandemic has neither clinically proven vaccine nor drugs; however, its patients are recovering with the aid of antibiotic medications, anti-viral drugs, and chloroquine as well as vitamin C supplementation. It is now evident that the world needs a speedy and...
Md Abdul Barek, Md. Abdul Aziz, Mohammad Safiqul Islam
PURPOSE: Severe acute respiratory coronavirus 2 (SARS-CoV-2) cases are overgrowing globally and now become a pandemic. A meta-analysis was conducted to evaluate the impact of age, sex, comorbidities, and clinical characteristics on the severity of COVID-19 to help diagnose and evaluate the current o...
Nadim Sharif, Khalid J. Alzahrani, Shamsun Nahar Ahmed, Shuvra Kanti Dey
There is a significant research gap in meta-analysis on the efficacy and safety of coronavirus disease 2019 (COVID-19) vaccines. This study analyzed the efficacy of COVID-19 vaccines. Published phase I, phase II, and phase III trials analyzing safety and immunogenicity and phase III randomized clini...
Xin Wang, You Li, Maria Deloria Knoll, Shabir A. Madhi et al.
BACKGROUND: Human metapneumovirus is a common virus associated with acute lower respiratory infections (ALRIs) in children. No global burden estimates are available for ALRIs associated with human metapneumovirus in children, and no licensed vaccines or drugs exist for human metapneumovirus infectio...
Timothy Russell, Nick Golding, Joel Hellewell, Sam Abbott et al.
BACKGROUND: Asymptomatic or subclinical SARS-CoV-2 infections are often unreported, which means that confirmed case counts may not accurately reflect underlying epidemic dynamics. Understanding the level of ascertainment (the ratio of confirmed symptomatic cases to the true number of symptomatic ind...
Mejbah Bhuiyan, Eunice Stiboy, Md Zakiul Hassan, Mei Chan et al.
Introduction Emerging evidence suggests young children are at greater risk of COVID-19 infection than initially predicted. However, a comprehensive understanding of epidemiology of COVID-19 infection in young children under five years, the most at-risk age-group for respiratory infections, remain un...
Taimur Islam, Anup Kumar Talukder, Md. Nurealam Siddiqui, Tofazzal Islam
An outbreak of a COVID-19 pandemic disease, caused by a novel coronavirus SARS-CoV-2, has posed a serious threat to global human health. Bangladesh has also come under the attack of this viral disease. Here, we aimed to describe the responses of Bangladesh to tackle the COVID-19, particularly on how...
Md. Martuza Ahamad, Sakifa Aktar, Md. Rashed-Al-Mahfuz, Shahadat Uddin et al.
Highlights • Machine learning was used to develop models to predict COVID-19 positive patient.• Features were extracted from patient data using string matching algorithms.• Constructed a novel dataset from unstructured hospitalized patient information.• Used descriptive statistical analysis for freq...
Ahsab Rahman, Tahani Tabassum, Yusha Araf, Abdullah Al Nahid et al.
The novel coronavirus disease 2019 (COVID-19) has become a severe health issue, especially to the patients who develop silent hypoxia condition after SARS-CoV-2 infection. Due to the lack of dyspnoea and extremely low oxygen saturation level, these patients are at exceptionally higher risk. Although...
Md. Mostaured Ali Khan, Md Nuruzzaman Khan, Md. Golam Mustagir, Juwel Rana et al.
BACKGROUND: Coronavirus disease 2019 (COVID-19), the most hectic pandemic of the era, is increasing exponentially and taking thousands of lives worldwide. This study aimed to assess the prevalence of pre-existing comorbidities among COVID-19 patients and their mortality risks with each category of p...
Sujita Kumar Kar, S. M. Yasir Arafat, Pawan Sharma, Ayushi Dixit et al.
Julia Bungenberg, Karen Humkamp, Christian Hohenfeld, Marcus Immanuel Rust et al.
Abstract Objectives We aimed to objectify and compare persisting self‐reported symptoms in initially hospitalized and non‐hospitalized patients after infection with severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) by applying clinical standardized measures. Methods We conducted a cross‐s...
Sina Salajegheh Tazerji, Phelipe Magalhães Duarte, Parastoo Rahimi, Fatemeh Shahabinejad et al.
COVID-19 caused by a novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) originated in Wuhan (Hubei province, China) during late 2019. It has spread across the globe affecting nearly 21 million people with a toll of 0.75 million deaths and restricting the movement of most of the world...